Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Italy
Keywords:
Acinetobacter baumannii, genotyping, carbapenem resistance genes, molecular epidemiology, ItalyAbstract
Background. Carbapenem-resistant (CR) Acinetobacter baumannii has been increasingly recognized as a major cause of health care-associated infections in critically ill patients and hospital outbreaks.
Methods. A narrative review of literature was conducted, searching PubMed database for articles on CR Acinetobacter spp. isolates from Italy published between January 2010 and December 2019.
Results. CR A. baumannii isolates assigned to international clonal lineage II (ICL II) and to ST78 clonal lineages were responsible for several epidemics in Italian hospitals during 2002-2018. Molecular analysis of carbapenem resistance showed the presence of OXA-58 CHDL in A. baumannii isolates assigned to ICL II and ST78 clonal lineage, which was replaced by OXA-23 CHDL in A. baumannii isolates assigned to ICL II since 2007 in several hospitals. CR A. baumannii was mainly responsible for respiratory tract infections and at a lesser extent for sepsis in intensive care unit patients.
Conclusions. Our data reinforces the need to monitor the molecular epidemiology of CR A. baumannii and its associated antimicrobial resistance genes at national level.
References
1. Zarrilli R, Pournaras S, Giannouli M, et al. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 2013; 41(1): 11-9.
2. Durante-Mangoni E, Utili R, Zarrilli R. Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date. Future Microbiol 2014; 9(6): 773-89.
3. Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol 2018; 16(2): 91-102.
4. Marí-Almirall M, Cosgaya C, Higgins P G, et al. MALDI-TOF/MS identification of species from the Acinetobacter baumannii (Ab) group revisited: inclusion of the novel A. seifertii and A. dijkshoorniae species. Clin Microbiol Infect 2017; 23(3): 210.e1-210.e9.
5. Pournaras S, Gogou V, Giannouli M, et al. Single-Locus-Sequence-Based Typing of blaOXA-51-like Genes for Rapid Assignment of Acinetobacter baumannii Clinical Isolates to International Clonal Lineages. J Clin Microbiol 2014; 52(5): 1653-7.
6. Gaiarsa S, Biffignandi GB, Esposito EP, et al. Comparative Analysis of the Two Acinetobacter baumannii Multilocus Sequence Typing (MLST) Schemes. Front Microbiol 2019; 10: 930.
7. Agodi A, Auxilia F, Barchitta M, et al. Trends, risk factors and outcomes of healthcare-associated infections within the Italian network SPINUTI. J Hosp Infect 2013; 84(1): 52-8.
8. Agodi A, Barchitta M, Auxilia F, et al. Epidemiology of intensive care unit-acquired sepsis in Italy: results of the SPIN-UTI network. Ann Ig 2018; 30(5 Suppl 2): 15-21.
9. Agodi A, Auxilia F, Barchitta M, et al. Antibiotic consumption and resistance: results of the SPINUTI project of the GISIO-SItI. Epidemiol Prev 2015; 39(4 Suppl 1): 94-8.
10. Hamidian M, Nigro SJ. Emergence, molecular mechanisms and global spread of carbapenemresistant Acinetobacter baumannii. Microb Genom 2019; 5(10).
11. Giannouli M, Antunes LCS, Marchetti V, et al. Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78. BMC Infect Dis. 2013; 13: 282.
12. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18(3): 268-81.
13. World Health Organization (WHO). Global
Priority List of Antibiotic-resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. 2017. Available on: https:// www.who.int/medicines/publications/globalpriority-list-antibiotic-resistant-bacteria/en/ [Last accessed 2020, July 7].
14. Agodi A, Voulgari E, Barchitta M, et al. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect 2014; 86(4): 260-6.
15. Perilli MG, Sabatini A, Pontieri E, et al. OXA-23 carbapenemase in multidrug-resistant Acinetobacter baumannii ST2 type: first identification in L’Aquila Hospital (Italy). Microb Drug Resist 2015; 21(1): 97-101.
16. Mammina C, Palma DM, Bonura C, et al. Epidemiology and clonality of carbapenem-resistant Acinetobacter baumannii from an intensive care unit in Palermo, Italy. BMC Res Notes 2012; 5: 365.
17. Mezzatesta ML, Caio C, Gona F, et al. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs. Int J Antimicrob Agents 2014; 44(2): 112-6.
18. Durante-Mangoni E, Del Franco M, Andini R, et al. Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 2015; 82(3): 222-6.
19. Caio C, Maugeri G, Zingali T, et al. Extensively drug-resistant ArmA-producing Acinetobacter baumannii in an Italian intensive care unit. New Microbiol 2018; 41(2): 159-161.
20. Lorenzin G, Scaltriti E, Gargiulo F, et al. Extensively drug-resistant Acinetobacter baumannii isolated from intensive care units in Northern Italy: a genomic approach to characterize new sequence types. Future Microbiol 2019; 14:1281-1292.
21. Cafiso V, Stracquadanio S, Lo Verde F, et al. Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy. Front Microbiol 2019; 9: 3195.
22. Giannouli M, Cuccurullo S, Crivaro V, et al. Molecular Epidemiology of Multidrug-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Naples, Italy, Shows the Emergence of a Novel Epidemic Clone. J Clin Microbiol 2010; 48(4): 1223-30.
23. Zarrilli R, Di Popolo A, Bagattini M, et al. Clonal spread and patient risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy. J Hosp Infect 2012; 82(4): 260-5.
24. Dettori M, Piana A, Deriu MG, et al. Outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit. New Microbiol 2014; 37(2): 185-91.
25. Piana A, Palmieri A, Deidda S, et al. Molecular typing of XDR Acinetobacter baumannii strains in an Italian ICU. Epidemiol Prev 2015; 39(4 Suppl 1): 129-33.
26. Milan A, Furlanis L, Cian F, et al. Epidemic Dissemination of a Carbapenem-Resistant Acinetobacter baumannii Clone Carrying armA Two Years After Its First Isolation in an Italian Hospital. Microb Drug Resist 2016; 22(8): 668-674.
27. Venditti C, Vulcano A, D’Arezzo S. Epidemiological investigation of an Acinetobacter baumannii outbreak using core genome multilocus sequence typing. J Glob Antimicrob Resist 2019; 17: 245-9.
28. Di Popolo A, Giannouli, Triassi M, et al. Molecular epidemiological investigation of multidrugresistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clin Microbiol Infect 2011; 17(2): 197-201.
29. Mezzatesta ML, D’Andrea MM, Migliavacca R, et al. Epidemiological characterization and distribution of carbapenem resistant Acinetobacter baumannii clinical isolates in Italy. Clin Microbiol Infect 2012; 18(2): 160-6.
30. Carretto E, Barbarini D, Dijkshoorn L, et al. Widespread carbapenem resistant Acinetobacter baumannii clones in Italian hospitals revealed by a multicenter study. Infect Genet Evol 2011; 11(6): 1319-26.
31. Minandri F, D’Arezzo S, Antunes LC, et al. Evidence of diversity among epidemiologically related carbapenemase-Producing Acinetobacter baumannii strains belonging to International clonal lineage II. J Clin Microbiol 2012; 50(3): 590-7.
32. Iacono M, Villa L, Fortini D, et al. Whole-genome pyrosequencing of an epidemic multidrugresistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob Agents Chemother 2008; 52(7): 2616-25.
33. Zarrilli R, Giannouli M, Rocco F, et al. Genome sequences of three Acinetobacter baumannii strains assigned to the multilocus sequence typing genotypes ST2, ST25, and ST78. J Bacteriol 2011; 193(9): 2359-60.
34. Pournaras S, Dafopoulou K, Del Franco M, et al. Predominance of international clone 2 OXA23-producing-Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study. Int J Antimicrob Agents 2017; 49(6): 74953.
35. Zarrilli R, Bagattini M, Esposito EP, et al. Acinetobacter infections in neonates. Curr Infect Dis Rep 2018; 20(12): 48.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.